1.03
2.83%
-0.03
Handel nachbörslich:
1.02
-0.01
-0.97%
Finanzdaten der Jaguar Health Inc-Aktie (JAGX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
2.22%
2.351
|
2.30 | 2.813 | 2.676 | 1.972 |
Cost Of Revenue |
37.41%
0.43
|
0.687 | 0.514 | 0.491 | 0.345 |
Gross Profit |
19.09%
1.921
|
1.613 | 2.299 | 2.185 | 1.627 |
Operating Expenses
|
10.53%
10.14
|
9.17 | 11.09 | 10.29 | 11.47 |
Interest Income/Expense |
146.37%
0.611
|
0.248 | 0.50 | 3.453 | 2.181 |
Benefits Costs and Expenses |
0.95%
11.72
|
11.61 | 10.72 | 14.97 | 14.37 |
Costs And Expenses |
7.19%
10.57
|
9.857 | 11.60 | 10.78 | 11.82 |
Operating Income/Loss |
8.71%
-8.215
|
-7.557 | -8.787 | -8.102 | -9.845 |
Income/Loss Before Equity Method Investments |
0.56%
-9.352
|
-9.30 | -7.899 | -12.29 | -12.37 |
Income/Loss From Equity Method Investments |
77.78%
-0.016
|
-0.009 | -0.005 | -0.006 | -0.031 |
Income/Loss From Continuing Operations Before Tax |
0.63%
-9.368
|
-9.309 | -7.904 | -12.29 | -12.40 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
0.63%
-9.368
|
-9.309 | -7.904 | -12.29 | -12.40 |
Net Income/Loss
|
0.63%
-9.368
|
-9.309 | -7.904 | -12.29 | -12.40 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
2.16%
-0.142
|
-0.139 | -0.126 | -0.141 | -0.195 |
Basic Average Shares |
1,765%
158.84
|
8.5176 | 20.74 | 17.63 | 5.1096 |
Diluted Average Shares |
1,765%
158.84
|
8.5176 | 20.74 | 29.11 | 5.1096 |
Basic Earnings Per Share |
114.29%
-0.06
|
0.42 | -0.38 | -0.69 | -2.39 |
Diluted Earnings Per Share |
114.29%
-0.06
|
0.42 | -0.38 | -0.42 | -2.39 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):